226 related articles for article (PubMed ID: 8252387)
1. Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats.
Kiefel JM; Rossi GC; Bodnar RJ
Brain Res; 1993 Oct; 624(1-2):151-61. PubMed ID: 8252387
[TBL] [Abstract][Full Text] [Related]
2. Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats.
Spinella M; Cooper ML; Bodnar RJ
Pain; 1996 Mar; 64(3):545-552. PubMed ID: 8783320
[TBL] [Abstract][Full Text] [Related]
3. Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia.
Kiefel JM; Cooper ML; Bodnar RJ
Brain Res; 1992 Dec; 597(2):331-8. PubMed ID: 1473004
[TBL] [Abstract][Full Text] [Related]
4. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats.
Pavlovic ZW; Cooper ML; Bodnar RJ
Brain Res; 1996 Nov; 741(1-2):13-26. PubMed ID: 9001699
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mesencephalic morphine analgesia by methysergide in the medial ventral medulla of rats.
Kiefel JM; Cooper ML; Bodnar RJ
Physiol Behav; 1992 Jan; 51(1):201-5. PubMed ID: 1311108
[TBL] [Abstract][Full Text] [Related]
6. Highly delta selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO.
Hirakawa N; Tershner SA; Fields HL
Neuroreport; 1999 Oct; 10(15):3125-9. PubMed ID: 10574547
[TBL] [Abstract][Full Text] [Related]
7. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
8. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
Kalra A; Urban MO; Sluka KA
J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioids acting at a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray.
Roychowdhury SM; Fields HL
Neuroscience; 1996 Oct; 74(3):863-72. PubMed ID: 8884782
[TBL] [Abstract][Full Text] [Related]
10. Opioid supraspinal analgesic synergy between the amygdala and periaqueductal gray in rats.
Pavlovic ZW; Bodnar RJ
Brain Res; 1998 Jan; 779(1-2):158-69. PubMed ID: 9473650
[TBL] [Abstract][Full Text] [Related]
11. Mu- and delta-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla.
Wang H; Wessendorf MW
Neuroscience; 2002; 109(3):619-34. PubMed ID: 11823071
[TBL] [Abstract][Full Text] [Related]
12. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
13. Synergistic brainstem interactions for morphine analgesia.
Rossi GC; Pasternak GW; Bodnar RJ
Brain Res; 1993 Oct; 624(1-2):171-80. PubMed ID: 8252389
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal interactions between the amygdala and ventrolateral periaqueductal gray in mediating of Q/N(1-17)-induced analgesia in the rat.
Shane R; Acosta J; Rossi GC; Bodnar RJ
Brain Res; 2003 Aug; 980(1):57-70. PubMed ID: 12865159
[TBL] [Abstract][Full Text] [Related]
15. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
Adams JU; Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
17. Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray.
Taylor BK; Basbaum AI
J Neurochem; 2003 Sep; 86(5):1129-41. PubMed ID: 12911621
[TBL] [Abstract][Full Text] [Related]
18. Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla.
Rossi GC; Pasternak GW; Bodnar RJ
Brain Res; 1994 Nov; 665(1):85-93. PubMed ID: 7882023
[TBL] [Abstract][Full Text] [Related]
19. Differential responses to morphine-induced analgesia in the tail-flick test.
Cecchi M; Capriles N; Watson SJ; Akil H
Behav Brain Res; 2008 Dec; 194(2):146-51. PubMed ID: 18656501
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine.
Paronis CA; Waddell AB; Holtzman SG
Pharmacol Biochem Behav; 1993 Dec; 46(4):813-7. PubMed ID: 8309960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
